Clinical Trial Update: A Study to Evaluate the Safety, Preliminary Efficacy, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis or Thyroid Eye Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of LASN01 in healthy subjects and patients with pulmonary fibrosis or thyroid eye disease has completed, assessing safety, preliminar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis
• Thyroid Eye Disease

Drugs mentioned

• LASN01

Snippet

Sponsor: Lassen Therapeutics 1 PTY LTD | Conditions: Pulmonary Fibrosis, Thyroid Eye Disease | Phase 1, Phase 2 | Status: COMPLETED